TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Strata Health Solutions Inc. (“Strata Health”), a leading provider of patient flow solutions internationally. Based in Canada, Strata Health designs, builds, and deploys software that improves access and navigation to care. Strata Health has over 80 health system partners and works with over 500 hospitals to provide over 800,000 pat ...

● . . VitalHub Corp. Recognized Among Top Performers in the 2024 TSX30 Ranking September 10, 2024 7:31 AM EDT | Source: Toronto Stock Exchange Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is proud to announce its inclusion in the 2024 TSX30™, the Toronto Stock Exchange's prestigious ranking of the top 30 performing stocks over the past three years. VitalHub has achieved the 26th position on this esteemed list, showcasing a r ...

VALHI REPORTS SECOND QUARTER 2024 RESULTS DALLAS, TEXAS . . August 8, 2024. Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $19.9 million, or $.70 per share, in the second quarter of 2024 compared to a net loss of $3.2 million, or $.11 per share, in the second quarter of 2023. For the first six months of 2024, Valhi reported net income attributable to Valhi stockholders of $27.7 million, or $.97 per share, compared to a net loss of $9.0 million, or $.31 per share, in the fi ...

Table of Contents as UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5467 VALHI, INC. (Exact name of Registrant as specified in its charter) Delaware 87-0110150 (State or other jurisdiction ...

Dallas, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $19.9 million, or $.70 per share, in the second quarter of 2024 compared to a net loss of $3.2 million, or $.11 per share, in the second quarter of 2023. For the first six months of 2024, Valhi reported net income attributable to Valhi stockholders of $27.7 million, or $.97 per share, compared to a net loss of $9.0 million, or $.31 per share, in the first six months of 2023. Net ...

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is pleased to announce that it has signed a definitive agreement (the "Definitive Agreement") to acquire MedCurrent Corporation and its subsidiaries ("MedCurrent"), by way of a courtapproved plan of arrangement under the provisions of the Business Corporations Act (Ontario) (the "Transaction"). "This acquisition represents a significant step forward in our mission to enhance healthcare delivery ...

TORONTO, July 25, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its second quarter 2024 ended June 30th, 2024, after market close on August 8th, 2024. The Company will subsequently hold a conference call via Zoom on August 9th, 2024, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow. https://us02web.zoom.us/webinar/register/WN_-Es4D85lTaCMdHGDz9A15 ...

Financial Performance - Valhi reported net income attributable to stockholders of $7.8 million, or $0.27 per share, in Q1 2024, compared to a net loss of $4.9 million, or $0.17 per share, in Q1 2023[1] - Valhi's total net sales increased by $37.9 million (7.7%) to $530.6 million in Q1 2024, with total operating income rising to $31.5 million from $2.5 million in Q1 2023[15] - Valhi's income before taxes improved to $18.0 million in Q1 2024 from a loss of $9.8 million in Q1 2023, with net income attributable to stockholders increasing by $12.7 million[15] Chemicals Segment Performance - The Chemicals Segment's net sales increased by $52.5 million (12%) to $478.8 million in Q1 2024, driven by a 28% increase in TiO2 sales volumes and a $4 million positive impact from currency exchange rates[4][13] - The Chemicals Segment's operating income improved to $22.8 million in Q1 2024 from an operating loss of $15.1 million in Q1 2023, with TiO2 production volumes up 15% and capacity utilization increasing from 76% to 87%[10] - The Chemicals Segment's unabsorbed fixed costs decreased by $10 million to $12 million in Q1 2024 compared to $22 million in Q1 2023, reflecting improved production rates[10] - Average TiO2 selling prices were 11% lower in Q1 2024 compared to Q1 2023, with a 2% decline during the quarter[4] Component Products Segment Performance - The Component Products Segment's net sales decreased by $3.2 million (7.8%) to $38.0 million in Q1 2024, with operating income declining to $3.7 million from $7.0 million in Q1 2023[3] Real Estate Management and Development Segment Performance - The Real Estate Management and Development Segment's sales decreased by $11.4 million (45.2%) to $13.8 million in Q1 2024 due to reduced development activity[14] Interest Expense - Interest expense increased by $4.3 million in Q1 2024, primarily due to higher interest rates on the Chemicals Segment's refinanced debt and a $1.5 million charge for deferred financing costs write-off[11]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Delaware 87-0110150 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5467 V ...

VALHI REPORTS FOURTH QUARTER 2023 RESULTS DALLAS, TEXAS . . March 7, 2024. Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $3.9 million, or $.14 per share, in the fourth quarter of 2023 compared to a net loss of $9.4 million, or $.33 per share, in the fourth quarter of 2022. For the full year of 2023, Valhi reported a net loss attributable to Valhi stockholders of $12.1 million, or $.42 per share, compared to net income of $90.2 million, or $3.16 per share, for the full yea ...